(Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies for multiple neuroinflammatory diseases that impact nearly 10 million people worldwide, ...
Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies for multiple neuroinflammatory ...
Health and space experts are warning that even a brief glance at the event without proper protection could cause permanent ...
A pivotal trial is now underway for i-Lumen AMD, a bioelectric therapy being investigated for intermediate to advanced dry ...
In 2017, a woman suffered severe vision impairment after gazing at a partial solar eclipse without protective eyewear. This led to solar retinopathy, manifesting as a crescent-shaped blind spot.
Zacks.com on MSN
KOD Begins Late-Stage Study of KSI-501 in Diabetic Macular Edema
Kodiak Sciences KOD announced that it initiated a global late-stage ALTO study evaluating KSI-501 in patients with diabetic ...
A Gemini-powered medical AI combined sight, sound, and clinical reasoning to match or outperform physicians on key measures in simulated video consultations, while revealing where human connection and ...
On the afternoon of 21 August 2017, millions of people across the United States looked towards the Sun as the Moon moved across it. For most viewers, the eclipse became a short-lived memory once the ...
New research challenges the dodo's long-held reputation for foolishness. Scientists used CT scans and digital brain ...
The FDA has granted Priority Review to Belite Bio's NDA for tinlarebant in Stargardt disease type 1, positioning it as a ...
Annexon, Inc. ( ANNX) Q2 2026 Earnings Call August 12, 2026 8:00 AM EDT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results